Heron Therapeutics (HRTX) Net Cash Flow (QoQ) (2010 - 2026)
Heron Therapeutics (HRTX) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Heron Therapeutics |
76.81 Mn |
46.84 Mn |
24.07 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
82.46% |
| Dec 31, 2025 |
-154.31% |
| Sep 30, 2025 |
1,064.48% |
| Jun 30, 2025 |
57.86% |
| Mar 31, 2025 |
-10,809.84% |
| Dec 31, 2024 |
-99.17% |
| Sep 30, 2024 |
456.35% |
| Jun 30, 2024 |
74.91% |
| Mar 31, 2024 |
-33.08% |
| Dec 31, 2023 |
-128.89% |
| Sep 30, 2023 |
257.01% |
| Jun 30, 2023 |
-216.22% |
| Mar 31, 2023 |
133.43% |
| Dec 31, 2022 |
-2,017.66% |
| Sep 30, 2022 |
122.03% |
| Jun 30, 2022 |
75.31% |
| Mar 31, 2022 |
51.28% |
| Dec 31, 2021 |
-118.43% |
| Sep 30, 2021 |
-124.04% |
| Jun 30, 2021 |
389.51% |
